Quest Partners LLC Capricor Therapeutics, Inc. Call Options Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CAPR
# of Institutions
112Shares Held
9.76MCall Options Held
1.8MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA2.28MShares$34.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$24.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$13.2 Million0.0% of portfolio
-
Altium Capital Management LP New York, NY714KShares$10.7 Million3.29% of portfolio
-
State Street Corp Boston, MA512KShares$7.7 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $366M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...